BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35418030)

  • 1. Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.
    Gallardo-Alvarado L; Cantú-de León D; Ramirez-Morales R; Santiago-Concha G; Barquet-Muñoz S; Salcedo-Hernandez R; Reyes C; Perez-Alvarez S; Perez-Montiel D; Perez-Plasencia C; Trejo-Duran E; Galicia JP
    BMC Cancer; 2022 Apr; 22(1):401. PubMed ID: 35418030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
    Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
    Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.
    Barquet-Muñoz SA; Cruz-Rodríguez E; Cantú De León DF; Isla-Ortiz D; Montalvo-Esquivel G; Herrera-Montalvo LA; Pérez-Plasencia C; Pérez-Montiel D; Herrera-Gómez Á
    Rev Invest Clin; 2017; 69(5):286-292. PubMed ID: 29077701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis.
    Legge F; Bizzarri N; Gallotta V; Pedone Anchora L; Cosentino F; Turco LC; Certelli C; Macchia G; Valentini V; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2022 Sep; 48(9):2045-2052. PubMed ID: 35450757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does histology influence prognosis in patients with early-stage cervical carcinoma?
    Grisaru D; Covens A; Chapman B; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2001 Dec; 92(12):2999-3004. PubMed ID: 11753977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
    Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
    J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
    Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
    Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
    Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy.
    Liu P; Ji M; Kong Y; Huo Z; Lv Q; Xie Q; Wang D; Chen B; Wang H; Cui Z; Wang Q; Bin X; Lang J; Chen C
    BMC Cancer; 2022 Mar; 22(1):326. PubMed ID: 35337279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Liu J; Tang G; Zhou Q; Kuang W
    Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T
    Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.